European Medicines Agency

Infarmed warns about the risks of using drugs with pseudoephedrine for hypertensive patients and patients with kidney disease

Infarmed recommends that patients with hypertension and kidney disease not take medications containing pseudoephedrine used to relieve cold and flu…

2 years ago

Infarmed warns about the risks of using drugs with pseudoephedrine for hypertensive patients and patients with kidney disease

Infarmed recommends that patients with hypertension and kidney disease not take medications containing pseudoephedrine used to relieve cold and flu…

2 years ago

Infarmed warns about the risks of using drugs with pseudoephedrine for hypertensive patients and patients with kidney disease

Infarmed recommends that patients with hypertension and kidney disease not take medications containing pseudoephedrine used to relieve cold and flu…

2 years ago

Infarmed warns about the risks of using drugs with pseudoephedrine for hypertensive patients and patients with kidney disease

Infarmed recommends that patients with hypertension and kidney disease not take medications containing pseudoephedrine used to relieve cold and flu…

2 years ago

Infarmed banned the export of 140 drugs

According to an information circular that comes into force this Friday, the National Medicines Authority (Infarmed) has banned the export…

2 years ago

European Commission green-lights bronchiolitis vaccine for pregnant women

The European Commission this Friday gave the green light to a vaccine marketed by the pharmaceutical company Pfizer and given…

2 years ago

Majority of respondents find it unacceptable to wait for cancer drug approval

The majority of respondents who participated in the breast cancer study are unaware of the difficulty of accessing new drugs…

2 years ago

Majority of respondents find it unacceptable to wait for cancer drug approval

The majority of respondents who participated in the breast cancer study are unaware of the difficulty of accessing new drugs…

2 years ago

Majority of respondents find it unacceptable to wait for cancer drug approval

The majority of respondents who participated in the breast cancer study are unaware of the difficulty of accessing new drugs…

2 years ago

Majority of respondents find it unacceptable to wait for cancer drug approval

The majority of respondents who participated in the breast cancer study are unaware of the difficulty of accessing new drugs…

2 years ago